12/10/2025China's Human Vaccine Market Set for Steady Long-Term Expansion

12/10/2025Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib

12/10/2025InnoCare Highlights Strong ASH25 Data for BCL2 Inhibitor Mesutoclax

12/10/2025Lepu Reports Encouraging Phase II Results for CD20-Targeted ADC Combo

12/10/2025China Launches First Commercial Insurance Drug List, Spotlighting High...

12/10/2025Pfizer Expands Obesity Pipeline With $150M Deal for Fosun Subsidiary's...

12/9/2025Ascletis Reports Positive Phase II Results for Oral GLP-1 Agonist ASC3...

12/9/2025US Set to Tighten Curbs on Chinese Biotech and Cross-Border Investment

12/9/2025Former CFDA Boss Bi Jingquan Expelled From Party, Faces Bribery Charge...

12/9/2025Pfizer, Lilly, J&J Among First Drugmakers to Secure Spots in China's N...

12/9/2025SanegeneBio Raises $110M+ in Series B Financing to Accelerate RNAi Pip...

More>>

12/9/2025Global Pharmas Turn to China Not Just for Assets, but for a New R&D Pl...

12/2/2025China Launches National Drug Price Registration System to Propel Marke...

12/2/2025NHC Releases 2024 China Health Statistics Bulletin

12/2/2025China Used to Be a Cash Cow for Western Companies. Now It's a Test Lab...

12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...

11/28/2025LEK: China's Clinical Trial Sector Enters a New Phase of Innovation an...

11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...

11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...

11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...

11/20/2025China Biopharma Tracker – October 2025 (PharmaDJ)

11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...

More>>